$RKLB

Klein Frank sold $6.3M of RKLB

Klein Frank (Chief Operations Officer) sold 44,390 shares of Rocket Lab Corp (RKLB) at an average of $142.57 ($139.41–$144.13, $6.33M total) across 6 trades on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klein Frank
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosure provides a concrete, dated insider selling event and transaction value, which can influence short-term sentiment but is not evidence of a new operational or financial change by itself.

02

Market read

The only actionable item is the disclosed $6.33M insider sale executed on 2026-05-26 and filed on 2026-05-28.

03

What to watch

Traders should check whether there were concurrent insider buys or other filings around the same period, since a single planned sale is often noise.

Relevance 5/10Novelty 4/10Timing: Filed 2026-05-28, discloses sales executed 2026-05-26.

Background

This is an SEC Form 4 insider transaction disclosure for Rocket Lab Corp, reported by its COO.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab COO Klein Frank sold about $6.33M of RKLB shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless paired with other negative company-specific news.

Evidence & confidence

The filing discloses transaction size, timing, and 10b5-1 pre-arrangement, which typically makes it less informative than unscheduled selling.

Market effects

No direct sector read-through beyond routine insider activity in space/launch equities.

None indicated.

None indicated.

Counterpoint

Because the sale is 10b5-1 planned, it may reflect liquidity needs rather than bearish expectations, so the market may overreact.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider transaction disclosure.

  • Klein Frank

    Chief Operations Officer who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.